Identification of side effects of COVID-19 drug candidates on embryogenesis using an integrated zebrafish screening platform
A Ernst, I Piragyte, AM Mp, ND Le, D Grandgirard… - Scientific reports, 2023 - nature.com
Drug repurposing is an important strategy in COVID-19 treatment, but many clinically
approved compounds have not been extensively studied in the context of embryogenesis …
approved compounds have not been extensively studied in the context of embryogenesis …
The potential of zebrafish as drug discovery research tool in immune-mediated inflammatory disease
C Smith - Inflammopharmacology, 2024 - Springer
Immune-mediated inflammatory disease (IMID) prevalence is estimated at 3–7% for
Westernised populations, with annual incidence reported at almost 1 in 100 people globally …
Westernised populations, with annual incidence reported at almost 1 in 100 people globally …
Off-label drug use during the COVID-19 pandemic in Africa: topic modelling and sentiment analysis of ivermectin in South Africa and Nigeria as a case study
Z Movahedi Nia, NL Bragazzi… - Journal of the …, 2023 - royalsocietypublishing.org
Although rejected by the World Health Organization, the human and even veterinary
formulation of ivermectin has widely been used for prevention and treatment of COVID-19. In …
formulation of ivermectin has widely been used for prevention and treatment of COVID-19. In …
Initial Characterization of the Viridisins' Biological Properties
Viridisin A1 and A2 were previously heterologously expressed, purified, and characterized
as ribosomally produced and post-translationally modified lanthipeptides. Such …
as ribosomally produced and post-translationally modified lanthipeptides. Such …